312 related articles for article (PubMed ID: 20038319)
21. Two cycles of cisplatin-based chemotherapy for low-volume stage II seminoma: results of a retrospective, single-center case series.
Pichler R; Leonhartsberger N; Stöhr B; Horninger W; Steiner H
Chemotherapy; 2012; 58(5):405-10. PubMed ID: 23296381
[TBL] [Abstract][Full Text] [Related]
22. Long term results and morbidity of paraaortic compared with paraaortic and iliac adjuvant radiation in clinical stage I seminoma.
Melchior D; Hammer P; Fimmers R; Schüller H; Albers P
Anticancer Res; 2001; 21(4B):2989-93. PubMed ID: 11712799
[TBL] [Abstract][Full Text] [Related]
23. Surveillance following orchiectomy for stage I testicular seminoma: long-term outcome.
Yoshida T; Kakimoto K; Takezawa K; Arai Y; Ono Y; Meguro N; Kinouchi T; Nishimura K; Usami M
Int J Urol; 2009 Sep; 16(9):756-9. PubMed ID: 19659679
[TBL] [Abstract][Full Text] [Related]
24. Relapse-free and overall survival in patients with pathologic stage II nonseminomatous germ cell cancer treated with etoposide and cisplatin adjuvant chemotherapy.
Kondagunta GV; Sheinfeld J; Mazumdar M; Mariani TV; Bajorin D; Bacik J; Bosl GJ; Motzer RJ
J Clin Oncol; 2004 Feb; 22(3):464-7. PubMed ID: 14752068
[TBL] [Abstract][Full Text] [Related]
25. Management of stage I testicular seminoma over a period of 49 years.
Detti B; Scoccianti S; Villari D; Cipressi S; Sardaro A; Simontacchi G; Livi L; Gacci M; Cai T; Greto D; Desideri I; Biti G
Onkologie; 2011; 34(10):510-4. PubMed ID: 21985849
[TBL] [Abstract][Full Text] [Related]
26. Risk-adapted treatment in clinical stage I testicular seminoma: the third Spanish Germ Cell Cancer Group study.
Aparicio J; Maroto P; del Muro XG; Gumà J; Sánchez-Muñoz A; Margelí M; Doménech M; Bastús R; Fernández A; López-Brea M; Terrassa J; Meana A; del Prado PM; Sastre J; Satrústegui JJ; Gironés R; Robert L; Germà JR
J Clin Oncol; 2011 Dec; 29(35):4677-81. PubMed ID: 22042940
[TBL] [Abstract][Full Text] [Related]
27. Treatment of Stage I Seminoma testis with extended field adjuvant radiation.
Mahantshetty U; Banerjee S; Kakkar S; Murthy V; Bakshi G; Tongaonkar HB; Shrivastava S
Gulf J Oncolog; 2012 Jan; (11):20-4. PubMed ID: 22227541
[TBL] [Abstract][Full Text] [Related]
28. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
Böhlen D; Borner M; Sonntag RW; Fey MF; Studer UE
J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858
[TBL] [Abstract][Full Text] [Related]
29. [A case of synchronous cervical lymph node metastases from testicular and thyroid cancers showing mixed response to chemotherapy].
Matsumoto H; Nakane H; Aoki A; Naito K; Imate Y; Ohkami K; Isoyama R
Hinyokika Kiyo; 2000 Jul; 46(7):505-8. PubMed ID: 10965461
[TBL] [Abstract][Full Text] [Related]
30. Testicular germ cell tumors in patients with human immunodeficiency virus infection.
Hentrich MU; Brack NG; Schmid P; Schuster T; Clemm C; Hartenstein RC
Cancer; 1996 May; 77(10):2109-16. PubMed ID: 8640678
[TBL] [Abstract][Full Text] [Related]
31. [Late relapse of stage I testicular seminoma after 11 years: successful treatment with chemotherapy alone].
Detti B; Cipressi S; Di Cataldo V; Biti G
Actas Urol Esp; 2010 Jan; 34(1):118-9. PubMed ID: 20223144
[No Abstract] [Full Text] [Related]
32. Long-term outcome of postorchiectomy surveillance for Stage I testicular seminoma.
Choo R; Thomas G; Woo T; Lee D; Kong B; Iscoe N; Danjoux C; Klotz L; Morton G; Chander S
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):736-40. PubMed ID: 15708251
[TBL] [Abstract][Full Text] [Related]
33. Patterns of relapse and treatment outcome after active surveillance or adjuvant carboplatin for stage I seminoma: a retrospective study of the Spanish Germ Cell Cancer Group.
Aparicio J; García Del Muro X; Maroto P; Terrasa J; Castellano D; Bastús R; Gumà J; Sagastibeltza N; Durán I; Ochenduszko S; Meana JA; García-Sánchez J; Arranz JA; Gironés R; Germà JR
Clin Transl Oncol; 2021 Jan; 23(1):58-64. PubMed ID: 32462393
[TBL] [Abstract][Full Text] [Related]
34. Pelvic recurrence in stage I seminoma: a new phenomenon that questions modern protocols for radiotherapy and follow-up.
Power RE; Kennedy J; Crown J; Fraser I; Thornhill JA
Int J Urol; 2005 Apr; 12(4):378-82. PubMed ID: 15948726
[TBL] [Abstract][Full Text] [Related]
35. Advanced seminoma--treatment results and prognostic factors for survival after first-line, cisplatin-based chemotherapy and for patients with recurrent disease: a single-institution experience in 145 patients.
Gholam D; Fizazi K; Terrier-Lacombe MJ; Jan P; Culine S; Theodore C
Cancer; 2003 Aug; 98(4):745-52. PubMed ID: 12910518
[TBL] [Abstract][Full Text] [Related]
36. Primary chemotherapy for stage 2 testis cancer.
Abratt RP; McAdam GL; Pontin AR; Barnes RD; Ball HS
S Afr J Surg; 1997 Nov; 35(4):203-5; discussion 205-6. PubMed ID: 9540399
[TBL] [Abstract][Full Text] [Related]
37. Long-term outcomes of radiotherapy for stage II testicular seminoma--the Mayo Clinic experience.
Hallemeier CL; Pisansky TM; Davis BJ; Choo R
Urol Oncol; 2013 Nov; 31(8):1832-8. PubMed ID: 22537538
[TBL] [Abstract][Full Text] [Related]
38. Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British Columbia.
Al-Tourah AJ; Murray N; Coppin C; Kollmannsberger C; Man A; Chi KN
J Urol; 2005 Dec; 174(6):2209-13, discussion 2213. PubMed ID: 16280765
[TBL] [Abstract][Full Text] [Related]
39. An alternative treatment regimen of advanced seminoma with carboplatin, etoposide, and bleomycin instead of cisplatin-based therapy.
Giesen E; Mager A; van Tinteren H; Rodenhuis S; Kerst JM
Urol Oncol; 2013 Jan; 31(1):110-4. PubMed ID: 21458311
[TBL] [Abstract][Full Text] [Related]
40. [Management of advanced seminoma: retrospective study of 96 patients].
Bompas E; Fléchon A; Biron P; Droz JP
Bull Cancer; 2002 Oct; 89(10):877-85. PubMed ID: 12441279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
